Cardiology
PURLs
Noncardiac inpatient has acute hypertension: Treat or not?
A retrospective study found more harm than benefit from treating elevated blood pressure in hospitalized noncardiac patients.
Conference Coverage
No invasive strategy benefit at 5 years in ISCHEMIA-CKD extension study
The trial speaks to the lofty high-risk status of patients with CAD. ‘You’re seeing in a group of patients, with largely preserved EF but advanced...
Guidelines
ACC/AHA issue chest pain data standards update to 2021 guideline
The data standards are an effort to harmonize the language around chest pain and should be “broadly applicable,” the work group says.
From the Journals
Artificial sweeteners linked to higher CV event risk
The first study to include artificial sweetener from all sources, not just drinks, may increase concerns about these agents. But not all are...
Latest News
Candy, desserts: A ‘gateway’ to unhealthy eating among teens
Over the past 30 years, there’s been a steady increase in consumption of ultra-processed foods worldwide, coupled with mounting evidence that...
From the Journals
Warfarin associated with higher upper GI bleeding rates, compared with DOACs
The risk of upper gastrointestinal bleeding was higher in men taking warfarin.
From the Journals
Early rhythm control improves cardiovascular outcomes in AFib patients regardless of stroke risk
The findings of a new study broaden support for early rhythm control.
From the Journals
Low physical function tied to cardiac events in older adults
“We found that physical function in older adults predicts future cardiovascular disease beyond traditional heart disease risk factors, regardless...
Conference Coverage
AI-assisted reading of echocardiograms readily detects severe aortic stenosis
Moderate and severe aortic stenosis is identified accurately on echocardiograms by artificial intelligence.
Conference Coverage
Majority of muscle symptoms with statins not caused by treatment
A new Cholesterol Trialists Collaboration meta-analysis shows that in 14 of the 15 people who experience muscle pain or weakness when taking a...
Conference Coverage
Evolocumab benefits accrue with longer follow-up: FOURIER OLE
Chief among the benefits was a reduction in cardiovascular mortality not observed in the pivotal trial that led to U.S. approval of evolocumab.